The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).
Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y)
Metra M.;
2021-01-01
Abstract
The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
